09/18/2012 - 9:44am

MinuteClinic and OU Physicians, Oklahoma's largest physician group with more than 560 doctors, have entered into a clinical affiliation to enhance access to healthcare services in Oklahoma.

09/17/2012 - 12:23pm

The CVS/pharmacy ExtraCare program, which boasts more than 70 million active members, now gives shoppers the ability to earn bigger rewards on most purchases during the peak fall and winter shopping season.

09/17/2012 - 8:37am

CVS Caremark has appointed Thomas Moriarty as EVP and general counsel of CVS Caremark.

09/12/2012 - 1:03pm

Most advertisements for over-the-counter versions of drugs did contain significantly less information about the risks of the medication, compared with the ads for the drug prior to its transition to OTC status, according to new research sponsored by CVS Caremark.

09/11/2012 - 10:06am

During Tuesday morning’s Morgan Stanley Healthcare Conference in New York City, CVS Caremark president and CEO Larry Merlo expressed optimism for a strong second half of the year and confidence in retaining a large portion of the prescription volumes gained from the Walgreens-Express Scripts impasse.

09/10/2012 - 8:53am

Amyotrophic lateral sclerosis patients from Chagrin Falls, Ohio, and cystic fibrosis patients from Indianapolis took part in pre-game, on-field traditions at Fenway Park to celebration CVS/pharmacy's Advancing Medical Research fundraising campaign, which raised more than $5 million in five weeks.

09/06/2012 - 9:44am

CVS Caremark announced that it has joined with a group of public and private sector partners and will sponsor the "The Medicine Abuse Project," a multiyear effort by The Partnership at Drugfree.org to raise awareness and curb the abuse of prescription drugs and over-the-counter medicines.

09/04/2012 - 8:41am

The CVS Caremark Charitable Trust and CVS/pharmacy have announced a donation of more than $20,000 in support of communities that have been affected by Hurricane Isaac.

08/29/2012 - 9:07am

In the battle to find a cure for amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease, scientists from Belgium have made a rare discovery: a new gene that influences survival time of ALS. The findings, reported in a recent issue of Nature Medicine, were funded in part by CVS/pharmacy and the ALS Therapy Alliance, a Boston-based nonprofit.